Rich And Richer: Bulgari CEO Sees U.S. Expansion

By CNBC.com Staff
Wednesday, 2 May 2007 | 10:30 AM ET

Luxury Italian jeweler Bulgari sees the U.S. as a "very interesting opportunity" and is clearly trying to cash in on the enormous wealth being generated by the private equity and hedge fund set.

Bulgari Plans to Expand in U.S.
Italian jeweler Bulgari has said that it sees potential in expanding into more U.S. cities and would like to increase its presence in U.S. department stores. CNBC's Margaret Brennan talks to Francesco Trapani, CEO of Bulgari, about the company's future plans.

In an interview with Margaret Brennan, Bulgari CEO Francesco Trapani acknowledged the importance of the two groups as new customers.

Bulgari, which recently refurbished its flagship U.S. store in New York City, says it is the "right timing" to expand in the U.S., having watched competitors successfully do so in recent years. The U.S. market is all the more important, as Japan, the world's largest luxury market, is "stagnating", says Trapani.

Bulgari has earmarked $100 million euro, or about $136 million dollars at current exchange rates, for capital spending in 2007, up from 60 million euros, or about $82 million, from the previous year.

Like many other players in the market, Bulgari is expanding its offering. This year it will roll out a skin care business in Italy, which it will bring to the U.S. in 2008 or 2009. It also recently opened hotels. Accessories now account for 10% of sales.

Trapani says "we want to be more interesting" at the point of sale.

  Price   Change %Change


Contact U.S. News


    Get the best of CNBC in your inbox

    › Learn More

Don't Miss

U.S. Video

  • Mad Money's Jim Cramer discusses Micron Technology and how the company gained control over inventory issues. The bears expect the company's history to repeat itself, but Cramer says this time, it feels different.

  • In this excerpt from a live CNBC interview, Warren Buffett explains why it's extremely unusual for a company's directors to vote against executive compensation plans.

  • Mad Money host Jim Cramer says shareholder activism works for every shareholder, and offers his take on the Valeant/Bill Ackman bid to acquire Allergan. The market is better off for these efforts, he says.